Aspen Notre-Dame-de-Bondeville recognizes worldwide as pharmaceutical reference site for sterile products since 50 years.
We manufacture and ship worldwide Fraxiparine™, Arixtra™, MonoEmbolex™ but also diluents used for reconstitution of vaccines prior to injection.
In 2018, the site commits to the manufacture of injectable anesthetic products.
We full master the criteria that ensure the absence of risk for the patient.
Every day and in each of our actions, we think of patients, they are counting on us.
3 Active ingredients
100 Millions euros of investments committed for the coming years
92% of our production is shipped overseas
Our certifications: ANVISA (Brazil), ANSM (France), EMA (Europe), FDA (USA), HPB (Canada), JMHRA (Japan)
Aspen has a Management System certified by DQS for OHSAS 18001 (Health / Safety) and ISO 14001 (Environment) standards